loading

Finanzdaten der Tyra Biosciences Inc-Aktie (TYRA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
10.84%
36.52
32.94 31.45 31.85 29.74
Operating Income/Loss
10.84%
-36.52
-32.94 -31.45 -31.85 -29.74
Nonoperating Income/Loss
12.81%
2.682
3.076 3.354 3.703 4.173
Income/Loss From Continuing Operations Before Tax
13.28%
-33.83
-29.87 -28.10 -28.15 -25.57
Income/Loss From Continuing Operations After Tax
13.28%
-33.83
-29.87 -28.10 -28.15 -25.57
Net Income/Loss
13.28%
-33.83
-29.87 -28.10 -28.15 -25.57
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.87%
0.0784
59.67 59.55 59.34 0.6187
Diluted Average Shares
99.87%
0.0784
59.67 59.55 59.34 0.6187
Basic Earnings Per Share
12.00%
-0.56
-0.50 -0.47 -0.47 -0.43
Diluted Earnings Per Share
12.00%
-0.56
-0.50 -0.47 -0.47 -0.43
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$46.06
price up icon 0.41%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$141.15
price up icon 1.23%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):